RxDoctor Payments DataLook up a doctor →

Stephen Ellen

Psychiatry · Nashua, NHNPI 1700825791

Payments from drug & device makers

$1,400,015in general payments, 2019–2025

Across 2,101 payments — averaging $666.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$873K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$225K
  • Axsome Therapeutics, Inc.$185K
  • Alkermes, Inc.$45K
  • Neurocrine Biosciences, Inc.$22K
  • Vanda Pharmaceuticals Inc.$14K
  • plus $37K from 16 others

What the payments were for

  • Consulting fees$108,1668%
  • Speaking & faculty fees$1,102,76879%
  • Travel & lodging$154,42911%
  • Food & beverage$34,5902%
  • Education$620%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,400,015 in reported general payments places this provider in the 95th percentile of 166 psychiatry providers in New Hampshire.

See all psychiatry providers in New Hampshire

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$85,100
VraylarCariprazine Hcl12$24,675
TrintellixVortioxetine Hydrobromide16$11,678
ConcertaMethylphenidate Hcl11$4,186
Aripiprazole26$2,354
Duloxetine Hcl136$2,348
Vilazodone Hcl15$1,610
Bupropion XlBupropion Hcl118$1,606
Methylphenidate ErMethylphenidate Hcl19$1,130
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine36$880
Modafinil12$597
Clonazepam91$580
Olanzapine25$491
Eszopiclone23$344
Mirtazapine32$343

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$21,794$85,10012 claims
AbbVieVraylar$873,200$24,67512 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$8,797$11,67816 claims
Johnson & JohnsonConcerta$45$4,18611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 166 psychiatry providers in New Hampshire.

Other psychiatry in Nashua

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →